Tuesday, July 3, 2007
Today's Globe: Genzyme defeat, helping a father die
Genzyme Corp. suffered an unaccustomed defeat yesterday when shareholders in Bioenvision Inc., a small New York cancer-drug developer, blocked a $350 million takeover bid by refusing to sell their stock to the Cambridge biotechnology giant.
What seem like comfort measures to one doctor would be certain euthanasia to another, Dr. Darshak Sanghavi, an assistant professor of pediatrics at the University of Massachusetts Medical School, writes on the op-ed page. This argument recently occurred over his father in a hospital intensive care unit.
Posted by Elizabeth Cooney at
06:36 AM
